Comparison of stereotactic body radiotherapy following transcatheter arterial chemoembolization vs transcatheter arterial chemoembolization alone in hepatocellular carcinoma

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 10

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. Oct 27, 2025; 17(10): 105360
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.105360

Full Size Figure Download Figure

Figure 1 Progression-free survival comparison between treatment groups: A Kaplan-Meier analysis. SBRT: Stereotactic body radiation therapy.

Citation: Chen L, Wang L, Wang H. Comparison of stereotactic body radiotherapy following transcatheter arterial chemoembolization vs transcatheter arterial chemoembolization alone in hepatocellular carcinoma. World J Gastrointest Surg 2025; 17(10): 105360
URL: https://www.wjgnet.com/1948-9366/full/v17/i10/105360.htm
DOI: https://dx.doi.org/10.4240/wjgs.v17.i10.105360

Chen L, Wang L, Wang H. Comparison of stereotactic body radiotherapy following transcatheter arterial chemoembolization vs transcatheter arterial chemoembolization alone in hepatocellular carcinoma. World J Gastrointest Surg 2025; 17(10): 105360 [PMID: 41178870 DOI: 10.4240/wjgs.v17.i10.105360]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.